Fed. Circ. Nixes Pronova's Patent Win Against Teva, Par
Pronova BioPharma Norge AS rendered its patent for the triglyceride-lowering drug Lovaza invalid when it sent a doctor samples of the drug before seeking a patent, the Federal Circuit ruled Thursday...To view the full article, register now.
Already a subscriber? Click here to view full article